Functional characterization and relevance of carnitine transporter OCTN2 to secondary carnitine deficiency.
Functional characterization and relevance of carnitine transporter OCTN2 to secondary carnitine deficiency.
批准号:
11672212
负责人:
TAMAI Ikumi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the present study, novel Na^+-dependent carnitine/organic cation transporter family, OCTNs from human and mouse were identified and functionally characterized. We isolated two and three members of OCTN family from human and mouse, respectively. OCTNs are present in various tissues, including kidney, heart, skeletal muscle and placenta strongly, and in several human-derived cancer cell lines. By immunohistochemical analysis in kidney, mouse OCTNs localized commonly in luminal membrane of tubular epithelial cells. Most of human and mouse OCTNs exhibited multifunctionality by transporting both of carnitine and organic cation, tetraethylammonium (TEA). Furthermore, sodium ions were essential for carnitine transport by human and mouse OCTN1 and 2. In systemic carnitine deficiency (SCD) phenotype mouse model, juvenile visceral steotosis (jvs) mouse, mutation in OCTN2 gene was found. Furthermore, several kinds of mutation in human SCD patients were found, demonstrating that OCTN2 is a physiologically important carnitine transporter. Interestingly, TEA transport was sodium independent. In addition, OCTNs transporterd various cationic drugs such as quinidine, verapamil, and actinomycin D.Furthermore, since one mutation of human OCTN2 lost carnitine transport activity but retained TEA transport activity, it was suggested that OCTN2 have differential functional sites for carnitine and organic cations. So, OCTNs are thought to be multifunctional transporters by transporting carnitine and organic cations by sodium ion dependent and independent manner, respectively, and would be important for disposition of organic cationic drugs as well as carnitine. Furthermore, since carnitine transport via OCTN2 is inhibited various compounds, including organic cations, organic anions such as valproic acid and neutral compound such as cortisole, it is anticipated that drug-induced secondary carnitine deficiency could be caused by interaction on OCTN2.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tamai,I.: "Molecular and functional characterization of carnitine/organic cation transporter family in mice"J.Biol, Chem.. 275・51. 40064-40072 (2000)
Tamai, I.:“小鼠肉毒碱/有机阳离子转运蛋白家族的分子和功能表征”J.Biol,Chem.. 275・51(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Yokogawa: "Loss of mild-type carrier-mediated L-carnitine transport activity in hepatocytes of Juvenile viscernal steatosis mice"Hepatology. 30. 997-1001 (1999)
K.Yokokawa:“幼年内脏脂肪变性小鼠肝细胞中轻度载体介导的左旋肉碱转运活性的丧失”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mayatepek, E.: "Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency."Hum.Mutat. (Online). 15 (1). 118 (2000)
Mayatepek, E.:“原发性全身性肉碱缺乏症患者中 OCTN2 基因的两个新错义突变(W283R 和 V446F)。”Hum.Mutat。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Yabuuchi: "Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transpot of organic cations"J. Pharmacol. Exp. Ther.. 289・2. 768-773 (1999)
H. Yabuuchi:“新型膜转运蛋白 OCTN1 介导有机阳离子的多特异性、双向和 pH 依赖性转运”J. Pharmacol. 289・2 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Yokogawa: "Characteristics of L-carnitine transport in cultured human hepatoma HLF cells"J. Pharm. Pharmacol. 51. 935-940 (1999)
K.Yokokawa:“培养的人肝癌 HLF 细胞中左旋肉碱转运的特征”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Application of Sandwich-cultured hepatocytes for analysis of drug-drug interaction on bile canalicular transporters
-
批准号:23659076
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:TAMAI Ikumi
-
依托单位:
Clarification and evaluation of regulation mechanism of uric acid
-
批准号:21390044
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2009
-
负责人:TAMAI Ikumi
-
依托单位:
Species difference in hepatic disposition of organic anions
-
批准号:19390046
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2007
-
负责人:TAMAI Ikumi
-
依托单位:
Establishment of Novel Anti-Hormone Therapy of Breast Cancer based on the Inhibition of Uptake Transporter of Conjugated Estrogen by Cancer Cells.
-
批准号:17390046
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2005
-
负责人:TAMAI Ikumi
-
依托单位:
Drug Toxicity Induced by Alteration of Transporter Activity
-
批准号:15390051
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.6万
-
财政年份:2003
-
负责人:TAMAI Ikumi
-
依托单位:
STUDIES FOR THE MECHANISM OF MULTIPLICITY IN SUBSTRATE SPECIFICITY OF TRANSPORTERS.
-
批准号:13470513
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:2001
-
负责人:TAMAI Ikumi
-
依托单位:
Evaluation of the blood-brain barrier based on the functional analysis of transporters using newly developed techniques.
-
批准号:12557229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.44万
-
财政年份:2000
-
负责人:TAMAI Ikumi
-
依托单位:
Molecular mechanism of blood-brain barrier transport of drugs.
-
批准号:09672221
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:TAMAI Ikumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
小立碗藓转录因子PpTF66调控离子通道PpSOT1在盐胁迫应答中的作用机制
-
批准号:31970658
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2019
-
负责人:何奕騉
-
依托单位:
肺炎支原体外排泵ABC Transporter在大环内酯类耐药中的作用机制研究
-
批准号:81672062
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2016
-
负责人:孙红妹
-
依托单位:
PICK1对心脏局部交感神经递质的平衡调控机制研究
-
批准号:31000472
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2010
-
负责人:靳文英
-
依托单位:
低氧诱导因子(HIF)以及氧化还原系统(redox)与肿瘤多药耐药(MDR)的相互作用
-
批准号:31070750
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:周捷
-
依托单位:
一个可能与水稻花粉发育相关的ABC transporter 基因的功能验证与分析
-
批准号:30970274
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:张毅
-
依托单位: